CSI Market
Sign In | Register

Pfizer Inc (PFE) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access PFE quarterly Cash Flow →
From Pfizer Inc through Dec 31 2021, changes in Dec 31 2025's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income7,812.00
Depreciation & amortization6,592.00
Amortization of Other Assets0.00
Asset impairment charges0.00
Asset Write Offs AndAsset Impairment Charges5,270.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories561.00
Gains on sales of products0.00
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal0.00
Share-based Compensation799.00
Stock-based compensation0.00
Taxes on exercise of stock options0.00
Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax-
Depreciation Depletion And Amortizationincludingdiscontinuedoperations-
Gainlossassociatedwiththetransferofcertainproductrightstoanequitymethodinvestment-
Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest7,787.00
Income taxes-4,938.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts Receivable-263.00
Increase (Decrease) in Accounts Payable, Trade-469.00
Pension contributions0.00
Other Accrued expenses0.00
Pension And Other Postretirement Benefit Contributions Net Of Pension And Other Postretirement Benefit Expense-786.00
Other Working Capital-2,378.00
Other Noncash Income (Expense)-470.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-7,838.00
Discontinued operations25.00
Net Cash flow from Operating Activities11,704.00
Investing Activities
Capital Expenditures-2,629.00
Sale of Capital Items0.00
Short-term Investments Proceeds3,603.00
Payments to Acquire Marketable Securities-294.00
Proceeds from other investments0.00
Proceeds From Short Term Loans-
Issuances Of Short Term Loans-
Proceeds From Redemption Of Long Term Loans-
Issuances Of Long Term Loans-
Payments For Proceeds From Short Term Investments With Original Maturities Of Three Months Or Less-2,675.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Proceeds from Sale, Maturity and Collection of Long-term Investments1,095.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-6,927.00
Proceeds from Sale of Equity Method Investments6,311.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities165.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1,351.00
Financing Activities
Short-term debt Net-2,995.00
Other borrowing transactions0.00
Long-term debt - borrowings9,678.00
Long-term debt - repayments-6,757.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock0.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-1,566.00
Repayments Of Short Term Debt Maturing In More Than Three Months Net Of Repayments Of Short Term Debt Maturing In Three Months Or Less-
Exhange Of Long Term Debt For Retirement Of Short Term Debt-
Receipt Of Common Stock For Retirement Of Short Term Debt-
Transfer Of Certain Product Rights To Equity Method Investment-
Noncash Or Part Noncash Acquisition Debt Assumed-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1,107.00
Noncashor Part Noncash Divestiture Amount of Consideration Received Common Stock-
Noncashor Part Noncash Divestiture Amount of Consideration Received Note Receivable-
Dividends paid to minority interests0.00
Dividends paid-9,771.00
Net Cash Flow from Financing Activities-10,304.00
Effect of exchange rate on cash flow41.00
Discontinued operations0.00
Free Cash Flow9,075.00
Total Cash Flow91.00
4 historic quarters locked

Sign in to unlock the full Pfizer Inc cash flow history.

Sign In Create Free Account

About Pfizer Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: pfe-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000078003-26-000026

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License